Kim Margolin
@kmargolin
Followers
314
Following
381
Media
4
Statuses
109
Joined February 2011
Congrats to @GlitzaMDPhD and MDACC colleagues for nivo iv and i.t. in melanoma w/leptomening spread—opening the field for more such creative work!!.
0
0
3
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results | Nature Medicine
nature.com
Nature Medicine - In an interim analysis of a phase 1 trial of concurrent intrathecal and intravenous anti-PD1 delivery in patients with leptomeningeal disease and melanoma, treatment was feasible...
0
0
3
#Melanoma Symposium, free .Join@EssnerRick@kmargolin@MLAscierto .Sat Apr30 Fairmont Santa Monica.@vernonsondak@jasonlukemd@alliegrossman @DrSancy.@drsapnapatel@drtrevanfischer@stevenkolkermd & Drs.RKorn,DHoon,PatrickOtt.
saintjohnscancer.org
Join the Melanoma Symposium at Saint John’s Cancer Institute to learn about the latest advancements in melanoma research and treatment. Engage with leading experts and discover new approaches to...
0
0
1
RT @DDoroshow: Thank you, #PaulFarmer, for helping grow a community of physicians pursuing serious study of the social sciences and humanit….
0
2
0
RT @MilkCartonKids: 1 of the upsides of being off the road for 18 months was learning how to stay connected without traveling, both with ea….
0
5
0
RT @joebeigemd: @NickTscherniaMD @allegriana Congrats to one of the smartest physicians I know- oncology or otherwise.
0
1
0
Breathtaking #SITC21 so much work done during worst of covid-Kudos Mary Dean, SITC staff, president @PatrickHwuMD , organizers, prog chair Sharma!
1
1
29
Fantastic job at first (still virtual) #SWOG #melanoma committee meeting by incoming chair @drsapnapatel—lots of new protocols on horizon with great correlates. Next spring in Seattle!!.
1
0
9
Nobel Prize in Physics Honors Work on Climate Change
nytimes.com
The work of Syukuro Manabe, Klaus Hasselmann and Giorgio Parisi “demonstrate that our knowledge about the climate rests on a solid scientific foundation,” the committee said.
0
0
1
RT @Jmarksloan: Can we all agree CDAs should NOT be needed just get a look at the schema and inclusion criteria of a pharma-sponsored tria….
0
3
0
RT @OmidHamidMD: Congrats @jasonlukemd Phase 3 KEYNOTE-716 .KEYTRUDA, @Merck anti-PD-1, met primary endpoint.(RFS) adjuvant high-risk stage….
0
16
0
RT @PittetLab: 21/ Finally, thanks to Dan Erkes @antidanimmunity and @SciImmunology for your interest in this work. Working with you has tr….
0
4
0